JUBLINGREA vs NOCIL: Stock Comparison

Jubilant Ingrevia Limited vs NOCIL Limited

Live data: 27 July 2026, 4:08 PM IST • Source: NSE and company filings

Jubilant Ingrevia Limited is the larger company by market capitalisation. Jubilant Ingrevia Limited shows a lower P/E, a higher ROE and faster revenue growth, while NOCIL Limited shows a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Jubilant Ingrevia Limited and NOCIL Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, JUBLINGREA is more favourable on 10 of 13 scored metrics and NOCIL on 3These counts are context-free and are not an overall rating.

Key Differences

Market Cap
JUBLINGREA is the larger company
₹11,835 Cr vs ₹2,725 Cr
P/E Ratio
JUBLINGREA has a lower P/E
37.41x vs 48.56x
P/B Ratio
NOCIL has a lower P/B
1.52x vs 3.69x
EPS
JUBLINGREA has higher earnings per share
₹18.39 vs ₹3.32
Dividend Yield
NOCIL has a higher dividend yield
1.12% vs 0.7%
Revenue Growth (TTM YoY)
JUBLINGREA has faster revenue growth
12.1% vs -2.8%
EPS Growth (TTM YoY)
JUBLINGREA has faster EPS growth
16.1% vs -19.2%
Qtr Sales Growth
JUBLINGREA has stronger quarterly sales growth
12.1% vs -2.75%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricJUBLINGREANOCIL
SectorChemicalsChemicals
IndustrySpecialty ChemicalsSpecialty Chemicals

Price

MetricJUBLINGREANOCIL
Live Price₹744.1₹163.03
Day Change2.56%1.82%
Volume4.46 L1.59 L
52-Week High₹845.55₹204.5
52-Week Low₹537.3₹125.31
Distance from 52W High-12%-20.28%

Valuation

MetricJUBLINGREANOCIL
Market Cap₹11,835 Cr₹2,725 Cr
P/E Ratio37.41x48.56x
P/B Ratio3.69x1.52x
EPS₹18.39₹3.32
Book Value₹197.83₹106.4
Dividend Yield0.7%1.12%

Growth

MetricJUBLINGREANOCIL
Revenue Growth (TTM YoY)12.1%-2.8%
EPS Growth (TTM YoY)16.1%-19.2%
Qtr Sales Growth12.1%-2.75%
Qtr Profit Growth16.7%-18.2%

Profitability & Leverage

MetricJUBLINGREANOCIL
ROE9.51%2.6%
ROCE11.4%3.93%
Net Margin6.61%4.86%
Operating Margin12.9%7.73%
Debt to Equity0.25x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricJUBLINGREANOCIL
Promoter Holding41.7%33.76%
FII Holding6.49%4.78% 0.23 pp
DII Holding24.98% 0.22 pp7.47% 0.44 pp
Public Holding22.29% 0.23 pp53.98% 0.2 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Jubilant Ingrevia Limited and NOCIL Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.